Second Sight Medical said today that it plans to raise $31.5 million in an initial public offering, likely next week.
Second Sight created the Argus II "bionic eye," the 1st retinal prosthesis approved for sale by the FDA.
The Medical Device Business Journal — Medical Device News & Articles | MassDevice
Second Sight Medical said today that it plans to raise $31.5 million in an initial public offering, likely next week.
Second Sight created the Argus II "bionic eye," the 1st retinal prosthesis approved for sale by the FDA.
Second Sight Medical is looking to bridge the gap to its forthcoming initial public offering with a $3 million loan from iconic chairman Al Mann.
Second Sight Medical announced this week that it landed a financial contract with the French Ministry of Health to provide funding for the 1st wave of patients in the country to receive treatment with the Argus II vision system.
Second Sight Medical hopes to raise $32 million through an initial public offering in support of its wearable visual prosthetics.
The company plans to offer shares at $9 apiece, saying it’ll used the proceeds from its IPO to boost sales & marketing, seek regulatory approvals in new regions and work on the next generation of its technology for helping restore vision to the blind.
A version of this story was originally posted on BetaBoston.com
In his hometown of Reed City, Mich., Roger Pontz is a dishwasher in a bowling alley bar. But in medical circles, he’s pioneering a new frontier.
Updated Jan. 29, 2014, at 11:10 a.m. with comment from Second Sight Medical.
Second Sight Medical today announced the 1st commercial U.S. implants of its Argus II bionic eye system, which won FDA approval about a year ago.
Second Sight Medical’s Argus II "bionic eye" is likely the most talked-about medical device of 2013.
The retinal prosthesis, approved by the FDA last summer, isn’t slated to hit the market until 2014, but the buzz around the device is already at a fever pitch.
Second Sight Medical released new results from a small study of its Argus II retinal prosthesis, reporting statistically significant improvement in object recognition in patients with a blinding genetic disease.
Shadow Robot Co.’s so-called bionic man is making its way across the world, parading about a $1 million worth of advanced medical prosthetics that allow him to walk, breath and even hold light conversation.
The bionic man, the 1st of his kind, is a composite of parts from various medical device makers, including robotic feet and ankles from Massachusetts-based BiOM, an artificial heart made by Arizona’s SynCardia Systems and a retinal prosthesis from California’s Second Sight Medical.
Cleveland Clinic this week announced its picks for the top 10 medical innovations of 2014, placing the newly FDA-approved Argus II "bionic eye" from Second Sight in the #1 spot.
The device is a breakthrough for the U.S., designed to restore meaningful eyesight to patients suffering from retinitis pigmentosa, a condition that leaves patients with either bare light perception or none at all. There is currently no cure for the rare condition, which is diagnosed about 250 times each year.